Urine findings that support glomerulonephritis in AKI include which of the following?

Prepare for the ITE Nephrology Test with a comprehensive study guide. Engage with flashcards and multiple-choice questions. Each question provides hints and explanations to help you succeed!

Multiple Choice

Urine findings that support glomerulonephritis in AKI include which of the following?

Explanation:
In AKI attributable to glomerular disease, the urine often shows red blood cell (RBC) casts and proteinuria because the glomerular basement membrane is damaged and leaks protein while blood cells escape into the filtrate and form casts in the tubules. The fractional excretion of sodium (FeNa) helps separate prerenal azotemia from intrinsic renal injury, but in glomerulonephritis the tubules can still reabsorb sodium well, so FeNa may remain relatively low (less than about 15%). Therefore, a finding of RBC casts and proteinuria with a FeNa under 15% supports glomerulonephritis as the cause of AKI. By contrast, eosinophils in urine point toward acute interstitial nephritis; muddy brown casts point to acute tubular necrosis; and a high FeNa with bland urine is typical of ATN rather than GN.

In AKI attributable to glomerular disease, the urine often shows red blood cell (RBC) casts and proteinuria because the glomerular basement membrane is damaged and leaks protein while blood cells escape into the filtrate and form casts in the tubules. The fractional excretion of sodium (FeNa) helps separate prerenal azotemia from intrinsic renal injury, but in glomerulonephritis the tubules can still reabsorb sodium well, so FeNa may remain relatively low (less than about 15%). Therefore, a finding of RBC casts and proteinuria with a FeNa under 15% supports glomerulonephritis as the cause of AKI.

By contrast, eosinophils in urine point toward acute interstitial nephritis; muddy brown casts point to acute tubular necrosis; and a high FeNa with bland urine is typical of ATN rather than GN.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy